Drug Discovery and Development: FDA moves against unapproved ingestible fluoride drugs for kids, citing risk-benefit concerns

FDA’s action follows a May–October review that included a Federal Register notice and public meeting organized with the Reagan-Udall Foundation and a docket to gather data on safety, clinical use and alternatives.